Global Chorionic Gonadotropin for Injection Market Growth 2025-2031

March 2025 | 84 pages | ID: G8550640EBDAEN
LP Information

Abstracts

The global Chorionic Gonadotropin for Injection market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Chorionic Gonadotropin for Injection is a medication that contains HCG and is used in fertility treatments and hormonal therapies.

United States market for Chorionic Gonadotropin for Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Chorionic Gonadotropin for Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Chorionic Gonadotropin for Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Chorionic Gonadotropin for Injection players cover Shanghai Livzon Pharmaceutical Co., Ltd., Qingdao Guanlong Biopharmaceutical Co., Ltd., Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd., Ningbo Renjian Pharmaceutical Group Co., Ltd., Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Chorionic Gonadotropin for Injection Industry Forecast” looks at past sales and reviews total world Chorionic Gonadotropin for Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Chorionic Gonadotropin for Injection sales for 2025 through 2031. With Chorionic Gonadotropin for Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chorionic Gonadotropin for Injection industry.

This Insight Report provides a comprehensive analysis of the global Chorionic Gonadotropin for Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chorionic Gonadotropin for Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chorionic Gonadotropin for Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chorionic Gonadotropin for Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chorionic Gonadotropin for Injection.

This report presents a comprehensive overview, market shares, and growth opportunities of Chorionic Gonadotropin for Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• u-hCG
• r-hCG

Segmentation by Application:

• Hospital
• Clinic
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Shanghai Livzon Pharmaceutical Co., Ltd.
• Qingdao Guanlong Biopharmaceutical Co., Ltd.
• Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd.
• Ningbo Renjian Pharmaceutical Group Co., Ltd.
• Merck

Key Questions Addressed in this Report

What is the 10-year outlook for the global Chorionic Gonadotropin for Injection market?

What factors are driving Chorionic Gonadotropin for Injection market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Chorionic Gonadotropin for Injection market opportunities vary by end market size?

How does Chorionic Gonadotropin for Injection break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Chorionic Gonadotropin for Injection Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Chorionic Gonadotropin for Injection by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Chorionic Gonadotropin for Injection by Country/Region, 2020, 2024 & 2031
2.2 Chorionic Gonadotropin for Injection Segment by Type
  2.2.1 u-hCG
  2.2.2 r-hCG
2.3 Chorionic Gonadotropin for Injection Sales by Type
  2.3.1 Global Chorionic Gonadotropin for Injection Sales Market Share by Type (2020-2025)
  2.3.2 Global Chorionic Gonadotropin for Injection Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Chorionic Gonadotropin for Injection Sale Price by Type (2020-2025)
2.4 Chorionic Gonadotropin for Injection Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Others
2.5 Chorionic Gonadotropin for Injection Sales by Application
  2.5.1 Global Chorionic Gonadotropin for Injection Sale Market Share by Application (2020-2025)
  2.5.2 Global Chorionic Gonadotropin for Injection Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Chorionic Gonadotropin for Injection Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Chorionic Gonadotropin for Injection Breakdown Data by Company
  3.1.1 Global Chorionic Gonadotropin for Injection Annual Sales by Company (2020-2025)
  3.1.2 Global Chorionic Gonadotropin for Injection Sales Market Share by Company (2020-2025)
3.2 Global Chorionic Gonadotropin for Injection Annual Revenue by Company (2020-2025)
  3.2.1 Global Chorionic Gonadotropin for Injection Revenue by Company (2020-2025)
  3.2.2 Global Chorionic Gonadotropin for Injection Revenue Market Share by Company (2020-2025)
3.3 Global Chorionic Gonadotropin for Injection Sale Price by Company
3.4 Key Manufacturers Chorionic Gonadotropin for Injection Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Chorionic Gonadotropin for Injection Product Location Distribution
  3.4.2 Players Chorionic Gonadotropin for Injection Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR CHORIONIC GONADOTROPIN FOR INJECTION BY GEOGRAPHIC REGION

4.1 World Historic Chorionic Gonadotropin for Injection Market Size by Geographic Region (2020-2025)
  4.1.1 Global Chorionic Gonadotropin for Injection Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Chorionic Gonadotropin for Injection Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Chorionic Gonadotropin for Injection Market Size by Country/Region (2020-2025)
  4.2.1 Global Chorionic Gonadotropin for Injection Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Chorionic Gonadotropin for Injection Annual Revenue by Country/Region (2020-2025)
4.3 Americas Chorionic Gonadotropin for Injection Sales Growth
4.4 APAC Chorionic Gonadotropin for Injection Sales Growth
4.5 Europe Chorionic Gonadotropin for Injection Sales Growth
4.6 Middle East & Africa Chorionic Gonadotropin for Injection Sales Growth

5 AMERICAS

5.1 Americas Chorionic Gonadotropin for Injection Sales by Country
  5.1.1 Americas Chorionic Gonadotropin for Injection Sales by Country (2020-2025)
  5.1.2 Americas Chorionic Gonadotropin for Injection Revenue by Country (2020-2025)
5.2 Americas Chorionic Gonadotropin for Injection Sales by Type (2020-2025)
5.3 Americas Chorionic Gonadotropin for Injection Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Chorionic Gonadotropin for Injection Sales by Region
  6.1.1 APAC Chorionic Gonadotropin for Injection Sales by Region (2020-2025)
  6.1.2 APAC Chorionic Gonadotropin for Injection Revenue by Region (2020-2025)
6.2 APAC Chorionic Gonadotropin for Injection Sales by Type (2020-2025)
6.3 APAC Chorionic Gonadotropin for Injection Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Chorionic Gonadotropin for Injection by Country
  7.1.1 Europe Chorionic Gonadotropin for Injection Sales by Country (2020-2025)
  7.1.2 Europe Chorionic Gonadotropin for Injection Revenue by Country (2020-2025)
7.2 Europe Chorionic Gonadotropin for Injection Sales by Type (2020-2025)
7.3 Europe Chorionic Gonadotropin for Injection Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Chorionic Gonadotropin for Injection by Country
  8.1.1 Middle East & Africa Chorionic Gonadotropin for Injection Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Chorionic Gonadotropin for Injection Revenue by Country (2020-2025)
8.2 Middle East & Africa Chorionic Gonadotropin for Injection Sales by Type (2020-2025)
8.3 Middle East & Africa Chorionic Gonadotropin for Injection Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Chorionic Gonadotropin for Injection
10.3 Manufacturing Process Analysis of Chorionic Gonadotropin for Injection
10.4 Industry Chain Structure of Chorionic Gonadotropin for Injection

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Chorionic Gonadotropin for Injection Distributors
11.3 Chorionic Gonadotropin for Injection Customer

12 WORLD FORECAST REVIEW FOR CHORIONIC GONADOTROPIN FOR INJECTION BY GEOGRAPHIC REGION

12.1 Global Chorionic Gonadotropin for Injection Market Size Forecast by Region
  12.1.1 Global Chorionic Gonadotropin for Injection Forecast by Region (2026-2031)
  12.1.2 Global Chorionic Gonadotropin for Injection Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Chorionic Gonadotropin for Injection Forecast by Type (2026-2031)
12.7 Global Chorionic Gonadotropin for Injection Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Shanghai Livzon Pharmaceutical Co., Ltd.
  13.1.1 Shanghai Livzon Pharmaceutical Co., Ltd. Company Information
  13.1.2 Shanghai Livzon Pharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Product Portfolios and Specifications
  13.1.3 Shanghai Livzon Pharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Shanghai Livzon Pharmaceutical Co., Ltd. Main Business Overview
  13.1.5 Shanghai Livzon Pharmaceutical Co., Ltd. Latest Developments
13.2 Qingdao Guanlong Biopharmaceutical Co., Ltd.
  13.2.1 Qingdao Guanlong Biopharmaceutical Co., Ltd. Company Information
  13.2.2 Qingdao Guanlong Biopharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Product Portfolios and Specifications
  13.2.3 Qingdao Guanlong Biopharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Qingdao Guanlong Biopharmaceutical Co., Ltd. Main Business Overview
  13.2.5 Qingdao Guanlong Biopharmaceutical Co., Ltd. Latest Developments
13.3 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd.
  13.3.1 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Company Information
  13.3.2 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Chorionic Gonadotropin for Injection Product Portfolios and Specifications
  13.3.3 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Chorionic Gonadotropin for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Main Business Overview
  13.3.5 Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Latest Developments
13.4 Ningbo Renjian Pharmaceutical Group Co., Ltd.
  13.4.1 Ningbo Renjian Pharmaceutical Group Co., Ltd. Company Information
  13.4.2 Ningbo Renjian Pharmaceutical Group Co., Ltd. Chorionic Gonadotropin for Injection Product Portfolios and Specifications
  13.4.3 Ningbo Renjian Pharmaceutical Group Co., Ltd. Chorionic Gonadotropin for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Ningbo Renjian Pharmaceutical Group Co., Ltd. Main Business Overview
  13.4.5 Ningbo Renjian Pharmaceutical Group Co., Ltd. Latest Developments
13.5 Merck
  13.5.1 Merck Company Information
  13.5.2 Merck Chorionic Gonadotropin for Injection Product Portfolios and Specifications
  13.5.3 Merck Chorionic Gonadotropin for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Merck Main Business Overview
  13.5.5 Merck Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. Chorionic Gonadotropin for Injection Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Chorionic Gonadotropin for Injection Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of u-hCG
Table 4. Major Players of r-hCG
Table 5. Global Chorionic Gonadotropin for Injection Sales byType (2020-2025) & (K Units)
Table 6. Global Chorionic Gonadotropin for Injection Sales Market Share byType (2020-2025)
Table 7. Global Chorionic Gonadotropin for Injection Revenue byType (2020-2025) & ($ million)
Table 8. Global Chorionic Gonadotropin for Injection Revenue Market Share byType (2020-2025)
Table 9. Global Chorionic Gonadotropin for Injection Sale Price byType (2020-2025) & (US$/Unit)
Table 10. Global Chorionic Gonadotropin for Injection Sale by Application (2020-2025) & (K Units)
Table 11. Global Chorionic Gonadotropin for Injection Sale Market Share by Application (2020-2025)
Table 12. Global Chorionic Gonadotropin for Injection Revenue by Application (2020-2025) & ($ million)
Table 13. Global Chorionic Gonadotropin for Injection Revenue Market Share by Application (2020-2025)
Table 14. Global Chorionic Gonadotropin for Injection Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global Chorionic Gonadotropin for Injection Sales by Company (2020-2025) & (K Units)
Table 16. Global Chorionic Gonadotropin for Injection Sales Market Share by Company (2020-2025)
Table 17. Global Chorionic Gonadotropin for Injection Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Chorionic Gonadotropin for Injection Revenue Market Share by Company (2020-2025)
Table 19. Global Chorionic Gonadotropin for Injection Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers Chorionic Gonadotropin for Injection Producing Area Distribution and Sales Area
Table 21. Players Chorionic Gonadotropin for Injection Products Offered
Table 22. Chorionic Gonadotropin for Injection Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Chorionic Gonadotropin for Injection Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Chorionic Gonadotropin for Injection Sales Market Share Geographic Region (2020-2025)
Table 27. Global Chorionic Gonadotropin for Injection Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Chorionic Gonadotropin for Injection Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Chorionic Gonadotropin for Injection Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Chorionic Gonadotropin for Injection Sales Market Share by Country/Region (2020-2025)
Table 31. Global Chorionic Gonadotropin for Injection Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Chorionic Gonadotropin for Injection Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Chorionic Gonadotropin for Injection Sales by Country (2020-2025) & (K Units)
Table 34. Americas Chorionic Gonadotropin for Injection Sales Market Share by Country (2020-2025)
Table 35. Americas Chorionic Gonadotropin for Injection Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Chorionic Gonadotropin for Injection Sales byType (2020-2025) & (K Units)
Table 37. Americas Chorionic Gonadotropin for Injection Sales by Application (2020-2025) & (K Units)
Table 38. APAC Chorionic Gonadotropin for Injection Sales by Region (2020-2025) & (K Units)
Table 39. APAC Chorionic Gonadotropin for Injection Sales Market Share by Region (2020-2025)
Table 40. APAC Chorionic Gonadotropin for Injection Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Chorionic Gonadotropin for Injection Sales byType (2020-2025) & (K Units)
Table 42. APAC Chorionic Gonadotropin for Injection Sales by Application (2020-2025) & (K Units)
Table 43. Europe Chorionic Gonadotropin for Injection Sales by Country (2020-2025) & (K Units)
Table 44. Europe Chorionic Gonadotropin for Injection Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Chorionic Gonadotropin for Injection Sales byType (2020-2025) & (K Units)
Table 46. Europe Chorionic Gonadotropin for Injection Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Chorionic Gonadotropin for Injection Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Chorionic Gonadotropin for Injection Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Chorionic Gonadotropin for Injection Sales byType (2020-2025) & (K Units)
Table 50. Middle East & Africa Chorionic Gonadotropin for Injection Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Chorionic Gonadotropin for Injection
Table 52. Key Market Challenges & Risks of Chorionic Gonadotropin for Injection
Table 53. Key IndustryTrends of Chorionic Gonadotropin for Injection
Table 54. Chorionic Gonadotropin for Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Chorionic Gonadotropin for Injection Distributors List
Table 57. Chorionic Gonadotropin for Injection Customer List
Table 58. Global Chorionic Gonadotropin for Injection SalesForecast by Region (2026-2031) & (K Units)
Table 59. Global Chorionic Gonadotropin for Injection RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Chorionic Gonadotropin for Injection SalesForecast by Country (2026-2031) & (K Units)
Table 61. Americas Chorionic Gonadotropin for Injection Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Chorionic Gonadotropin for Injection SalesForecast by Region (2026-2031) & (K Units)
Table 63. APAC Chorionic Gonadotropin for Injection Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Chorionic Gonadotropin for Injection SalesForecast by Country (2026-2031) & (K Units)
Table 65. Europe Chorionic Gonadotropin for Injection RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Chorionic Gonadotropin for Injection SalesForecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Chorionic Gonadotropin for Injection RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Chorionic Gonadotropin for Injection SalesForecast byType (2026-2031) & (K Units)
Table 69. Global Chorionic Gonadotropin for Injection RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Chorionic Gonadotropin for Injection SalesForecast by Application (2026-2031) & (K Units)
Table 71. Global Chorionic Gonadotropin for Injection RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Shanghai Livzon Pharmaceutical Co., Ltd. Basic Information, Chorionic Gonadotropin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Shanghai Livzon Pharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Product Portfolios and Specifications
Table 74. Shanghai Livzon Pharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Shanghai Livzon Pharmaceutical Co., Ltd. Main Business
Table 76. Shanghai Livzon Pharmaceutical Co., Ltd. Latest Developments
Table 77. Qingdao Guanlong Biopharmaceutical Co., Ltd. Basic Information, Chorionic Gonadotropin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. Qingdao Guanlong Biopharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Product Portfolios and Specifications
Table 79. Qingdao Guanlong Biopharmaceutical Co., Ltd. Chorionic Gonadotropin for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Qingdao Guanlong Biopharmaceutical Co., Ltd. Main Business
Table 81. Qingdao Guanlong Biopharmaceutical Co., Ltd. Latest Developments
Table 82. Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Basic Information, Chorionic Gonadotropin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Chorionic Gonadotropin for Injection Product Portfolios and Specifications
Table 84. Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Chorionic Gonadotropin for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Main Business
Table 86. Shaanxi Pharmaceutical Holding Group Biological Products Co., Ltd. Latest Developments
Table 87. Ningbo Renjian Pharmaceutical Group Co., Ltd. Basic Information, Chorionic Gonadotropin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Ningbo Renjian Pharmaceutical Group Co., Ltd. Chorionic Gonadotropin for Injection Product Portfolios and Specifications
Table 89. Ningbo Renjian Pharmaceutical Group Co., Ltd. Chorionic Gonadotropin for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Ningbo Renjian Pharmaceutical Group Co., Ltd. Main Business
Table 91. Ningbo Renjian Pharmaceutical Group Co., Ltd. Latest Developments
Table 92. Merck Basic Information, Chorionic Gonadotropin for Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Merck Chorionic Gonadotropin for Injection Product Portfolios and Specifications
Table 94. Merck Chorionic Gonadotropin for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Merck Main Business
Table 96. Merck Latest Developments



LIST OFFIGURES

Figure 1. Picture of Chorionic Gonadotropin for Injection
Figure 2. Chorionic Gonadotropin for Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Chorionic Gonadotropin for Injection Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Chorionic Gonadotropin for Injection Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Chorionic Gonadotropin for Injection Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Chorionic Gonadotropin for Injection Sales Market Share by Country/Region (2024)
Figure 10. Chorionic Gonadotropin for Injection Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of u-hCG
Figure 12. Product Picture of r-hCG
Figure 13. Global Chorionic Gonadotropin for Injection Sales Market Share byType in 2025
Figure 14. Global Chorionic Gonadotropin for Injection Revenue Market Share byType (2020-2025)
Figure 15. Chorionic Gonadotropin for Injection Consumed in Hospital
Figure 16. Global Chorionic Gonadotropin for Injection Market: Hospital (2020-2025) & (K Units)
Figure 17. Chorionic Gonadotropin for Injection Consumed in Clinic
Figure 18. Global Chorionic Gonadotropin for Injection Market: Clinic (2020-2025) & (K Units)
Figure 19. Chorionic Gonadotropin for Injection Consumed in Others
Figure 20. Global Chorionic Gonadotropin for Injection Market: Others (2020-2025) & (K Units)
Figure 21. Global Chorionic Gonadotropin for Injection Sale Market Share by Application (2024)
Figure 22. Global Chorionic Gonadotropin for Injection Revenue Market Share by Application in 2025
Figure 23. Chorionic Gonadotropin for Injection Sales by Company in 2025 (K Units)
Figure 24. Global Chorionic Gonadotropin for Injection Sales Market Share by Company in 2025
Figure 25. Chorionic Gonadotropin for Injection Revenue by Company in 2025 ($ millions)
Figure 26. Global Chorionic Gonadotropin for Injection Revenue Market Share by Company in 2025
Figure 27. Global Chorionic Gonadotropin for Injection Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Chorionic Gonadotropin for Injection Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Chorionic Gonadotropin for Injection Sales 2020-2025 (K Units)
Figure 30. Americas Chorionic Gonadotropin for Injection Revenue 2020-2025 ($ millions)
Figure 31. APAC Chorionic Gonadotropin for Injection Sales 2020-2025 (K Units)
Figure 32. APAC Chorionic Gonadotropin for Injection Revenue 2020-2025 ($ millions)
Figure 33. Europe Chorionic Gonadotropin for Injection Sales 2020-2025 (K Units)
Figure 34. Europe Chorionic Gonadotropin for Injection Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Chorionic Gonadotropin for Injection Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Chorionic Gonadotropin for Injection Revenue 2020-2025 ($ millions)
Figure 37. Americas Chorionic Gonadotropin for Injection Sales Market Share by Country in 2025
Figure 38. Americas Chorionic Gonadotropin for Injection Revenue Market Share by Country (2020-2025)
Figure 39. Americas Chorionic Gonadotropin for Injection Sales Market Share byType (2020-2025)
Figure 40. Americas Chorionic Gonadotropin for Injection Sales Market Share by Application (2020-2025)
Figure 41. United States Chorionic Gonadotropin for Injection Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Chorionic Gonadotropin for Injection Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Chorionic Gonadotropin for Injection Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Chorionic Gonadotropin for Injection Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Chorionic Gonadotropin for Injection Sales Market Share by Region in 2025
Figure 46. APAC Chorionic Gonadotropin for Injection Revenue Market Share by Region (2020-2025)
Figure 47. APAC Chorionic Gonadotropin for Injection Sales Market Share byType (2020-2025)
Figure 48. APAC Chorionic Gonadotropin for Injection Sales Market Share by Application (2020-2025)
Figure 49. China Chorionic Gonadotropin for Injection Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Chorionic Gonadotropin for Injection Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Chorionic Gonadotropin for Injection Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Chorionic Gonadotropin for Injection Revenue Growth 2020-2025 ($ millions)
Figure 53. India Chorionic Gonadotropin for Injection Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Chorionic Gonadotropin for Injection Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan Chorionic Gonadotropin for Injection Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Chorionic Gonadotropin for Injection Sales Market Share by Country in 2025
Figure 57. Europe Chorionic Gonadotropin for Injection Revenue Market Share by Country (2020-2025)
Figure 58. Europe Chorionic Gonadotropin for Injection Sales Market Share byType (2020-2025)
Figure 59. Europe Chorionic Gonadotropin for Injection Sales Market Share by Application (2020-2025)
Figure 60. Germany Chorionic Gonadotropin for Injection Revenue Growth 2020-2025 ($ millions)
Figure 61.France Chorionic Gonadotropin for Injection Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Chorionic Gonadotropin for Injection Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Chorionic Gonadotropin for Injection Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Chorionic Gonadotropin for Injection Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Chorionic Gonadotropin for Injection Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Chorionic Gonadotropin for Injection Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa Chorionic Gonadotropin for Injection Sales Market Share by Application (2020-2025)
Figure 68. Egypt Chorionic Gonadotropin for Injection Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Chorionic Gonadotropin for Injection Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Chorionic Gonadotropin for Injection Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey Chorionic Gonadotropin for Injection Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Chorionic Gonadotropin for Injection Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Chorionic Gonadotropin for Injection in 2025
Figure 74. Manufacturing Process Analysis of Chorionic Gonadotropin for Injection
Figure 75. Industry Chain Structure of Chorionic Gonadotropin for Injection
Figure 76. Channels of Distribution
Figure 77. Global Chorionic Gonadotropin for Injection Sales MarketForecast by Region (2026-2031)
Figure 78. Global Chorionic Gonadotropin for Injection Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global Chorionic Gonadotropin for Injection Sales Market ShareForecast byType (2026-2031)
Figure 80. Global Chorionic Gonadotropin for Injection Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global Chorionic Gonadotropin for Injection Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global Chorionic Gonadotropin for Injection Revenue Market ShareForecast by Application (2026-2031)